drugset / Trial / NCT07062601

Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children

NCT07062601

Not yet recruiting 64 enrolled Anqing Municipal Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Objective: To explore the effect of etomidate and esketamine on postoperative pain after tonsillectomy in children. Methods: Investigators enrolled 64 children with American Society of Anesthesiologists (ASA) physical status I and II, aged 2-10 years, and scheduled for elective undergoing tonsillectomy with general anesthesia. All the enrolled patients were randomly divided into etomidate and fentanyl group (Group A) and etomidate and esketamine group (Group B). In the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively; in the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation. Anesthesiologists who were unaware of the grouping recorded the FlACC Pain Scale at 2 h, 8 h, and 24 h after surgery.

Timeline

Start
2025-07-10
Primary completion
2025-11-10
Completion
2025-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.5 mg/kg
Subject Fentanyl Other / unclassified 4 ug/kg
Background Etomidate Small molecule 0.3 mg/kg
Background Propofol Small molecule 4 mg/kg
Background Propofol Small molecule 12 mg/kg
Background Remifentanil Small molecule 3 ug/kg
Background Remifentanil Small molecule 6 ug/kg

Indications